Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen spray for sore throat due to upper respiratory tract infection
ACTRN12612000457842Phase 3Completed
- Sponsor
- Novotech
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in upper respiratory infection (URI) comparing Flurbiprofen spray with Placebo spray (2 arms). Primary endpoint: Severity of throat soreness over 0 to 2 hours. Started May 2012; status: completed.
02
Drugs
flurbiprofen
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on ACTRN12612000457842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000457842.